BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 22047364)

  • 1. Improving suspicious breast lesion characterization using semi-automatic lesion fractional volume washout kinetic analysis.
    Huang J; Hahn T; Hoisington L; Schafer S; Zong X; Berger K
    Med Phys; 2011 Nov; 38(11):5998-6009. PubMed ID: 22047364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using lesion washout volume fraction as a biomarker to improve suspicious breast lesion characterization.
    Huang J; Schafer SM; Aben GR; Hoisington LA
    J Appl Clin Med Phys; 2015 Sep; 16(5):389–395. PubMed ID: 26699291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI-detected suspicious breast lesions: predictive values of kinetic features measured by computer-aided evaluation.
    Wang LC; DeMartini WB; Partridge SC; Peacock S; Lehman CD
    AJR Am J Roentgenol; 2009 Sep; 193(3):826-31. PubMed ID: 19696298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI.
    Chen W; Giger ML; Bick U; Newstead GM
    Med Phys; 2006 Aug; 33(8):2878-87. PubMed ID: 16964864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic approach for dynamic breast MRI to indicate signal intensity time curves of benign and malignant lesions by using the tumor flow residence time.
    Renz DM; Diekmann F; Schmitzberger FF; Pietsch H; Fallenberg EM; Durmus T; Huppertz A; Böttcher J; Bick U; Hamm B; Lawaczeck R
    Invest Radiol; 2013 Feb; 48(2):69-78. PubMed ID: 23262793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast DCE-MRI: influence of postcontrast timing on automated lesion kinetics assessments and discrimination of benign and malignant lesions.
    Partridge SC; Stone KM; Strigel RM; DeMartini WB; Peacock S; Lehman CD
    Acad Radiol; 2014 Sep; 21(9):1195-203. PubMed ID: 24998690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of spatiotemporal changes for the classification of dynamic contrast-enhanced magnetic-resonance breast lesions.
    Milenković J; Hertl K; Košir A; Zibert J; Tasič JF
    Artif Intell Med; 2013 Jun; 58(2):101-14. PubMed ID: 23548472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separation of benign and malignant breast lesions using dynamic contrast enhanced MRI in a biopsy cohort.
    Kim SG; Freed M; Leite APK; Zhang J; Seuss C; Moy L
    J Magn Reson Imaging; 2017 May; 45(5):1385-1393. PubMed ID: 27766710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A computer-aided diagnosis system for breast DCE-MRI at high spatiotemporal resolution.
    Dalmış MU; Gubern-Mérida A; Vreemann S; Karssemeijer N; Mann R; Platel B
    Med Phys; 2016 Jan; 43(1):84. PubMed ID: 26745902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution.
    Kuhl CK; Schild HH; Morakkabati N
    Radiology; 2005 Sep; 236(3):789-800. PubMed ID: 16118161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An A.I. classifier derived from 4D radiomics of dynamic contrast-enhanced breast MRI data: potential to avoid unnecessary breast biopsies.
    Pötsch N; Dietzel M; Kapetas P; Clauser P; Pinker K; Ellmann S; Uder M; Helbich T; Baltzer PAT
    Eur Radiol; 2021 Aug; 31(8):5866-5876. PubMed ID: 33744990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-T dynamic contrast-enhanced MRI of the breast: pharmacokinetic parameters versus conventional kinetic curve analysis.
    El Khouli RH; Macura KJ; Kamel IR; Jacobs MA; Bluemke DA
    AJR Am J Roentgenol; 2011 Dec; 197(6):1498-505. PubMed ID: 22109308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of breast mass lesions using model-based analysis of the characteristic kinetic curve derived from fuzzy c-means clustering.
    Chang YC; Huang YH; Huang CS; Chang PK; Chen JH; Chang RF
    Magn Reson Imaging; 2012 Apr; 30(3):312-22. PubMed ID: 22245697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-phase dynamic breast magnetic resonance imaging with two-way subtraction.
    Choi N; Han BK; Choe YH; Kim HS
    J Comput Assist Tomogr; 2005; 29(6):834-41. PubMed ID: 16272861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application value of 3T ¹H-magnetic resonance spectroscopy in diagnosing breast tumors.
    Vassiou K; Tsougos I; Kousi E; Vlychou M; Athanasiou E; Theodorou K; Arvanitis DL; Fezoulidis IV
    Acta Radiol; 2013 May; 54(4):380-8. PubMed ID: 23436823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computer-aided diagnosis of breast DCE-MRI using pharmacokinetic model and 3-D morphology analysis.
    Wang TC; Huang YH; Huang CS; Chen JH; Huang GY; Chang YC; Chang RF
    Magn Reson Imaging; 2014 Apr; 32(3):197-205. PubMed ID: 24439361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computerized breast lesions detection using kinetic and morphologic analysis for dynamic contrast-enhanced MRI.
    Chang YC; Huang YH; Huang CS; Chen JH; Chang RF
    Magn Reson Imaging; 2014 Jun; 32(5):514-22. PubMed ID: 24582545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparametric MR Imaging with High-Resolution Dynamic Contrast-enhanced and Diffusion-weighted Imaging at 7 T Improves the Assessment of Breast Tumors: A Feasibility Study.
    Pinker K; Baltzer P; Bogner W; Leithner D; Trattnig S; Zaric O; Dubsky P; Bago-Horvath Z; Rudas M; Gruber S; Weber M; Helbich TH
    Radiology; 2015 Aug; 276(2):360-70. PubMed ID: 25751227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic Analysis of Lesions Identified on a Rapid Abridged Multiphase (RAMP) Breast MRI Protocol.
    Choudhery S; Chou SS; Chang K; Kalpathy-Cramer J; Lehman CD
    Acad Radiol; 2020 May; 27(5):672-681. PubMed ID: 31147233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation between subcentimeter carcinomas and benign lesions using kinetic parameters derived from ultrafast dynamic contrast-enhanced breast MRI.
    Onishi N; Sadinski M; Gibbs P; Gallagher KM; Hughes MC; Ko ES; Dashevsky BZ; Shanbhag DD; Fung MM; Hunt TM; Martinez DF; Shukla-Dave A; Morris EA; Sutton EJ
    Eur Radiol; 2020 Feb; 30(2):756-766. PubMed ID: 31468162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.